Larvol Delta - Immunogenicity-and-Safety-Study-of-SCB2023-Vaccine-as-a-Booster-in-Adults

SCB-2019 - Sichuan Clover Biopharma

http://clinicaltrials.gov/ct2/show/NCT05926440

Jul 3, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next